Efficacy of Antibiotic Regimens for Pneumonia in Young Infants Aged 0-59 Days: A Systematic Review
Krysten North1,2, Alejandro Frade Garcia3, Mark Crouch4
1Department of Pediatrics, Brigham and Women's Hospital, Boston, Massachusetts.
Insights
Limited evidence supports specific antibiotic regimens for treating young infant pneumonia. This systematic review found no single antibiotic regimen to be superior for critical clinical outcomes in infants with pneumonia.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Pharmacology
Background:
- Pneumonia is a significant cause of mortality in young infants globally.
- Effective antibiotic treatment is crucial for improving infant survival rates.
Purpose of the Study:
- To evaluate the efficacy of various antibiotic regimens for treating pneumonia in young infants.
- To assess the impact of different antibiotic treatments on critical clinical outcomes.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched multiple databases including MEDLINE, Embase, CINAHL, and WHO Global Index Medicus.
- Included RCTs involving infants aged 0-59 days with pneumonia, comparing antibiotic regimens.
- Assessed risk of bias and certainty of evidence using GRADE methodology.
Main Results:
- Ten RCTs involving 5198 infants were included; 7 were hospital-based and 3 nonhospital-based.
- No hospital-based trials evaluated WHO-recommended first-line treatments.
- One trial indicated cefotaxime (WHO second-choice) had similar success rates to non-WHO regimens.
- Nonhospital-based trials showed no difference in treatment failure between oral amoxicillin and alternatives for tachypnea.
Conclusions:
- Limited evidence exists to support the superiority of any single antibiotic regimen for young infant pneumonia.
- Further high-quality research is needed to guide optimal antibiotic selection.
- Current evidence suggests low certainty for primary outcomes across evaluated regimens.
Context:
Pneumonia is a leading cause of death in young infants.
Objectives:
To evaluate the efficacy of different antibiotic regimens to treat young infant pneumonia on critical clinical outcomes.
Data Sources:
MEDLINE, Embase, CINAHL, World Health Organization (WHO) Global Index Medicus, Cochrane Central Registry of Trials.
Study Selection:
We included randomized controlled trials of young infants aged 0 to 59 days with pneumonia (population) comparing the efficacy of antibiotic regimens (intervention) with alternate regimens or management (control) on clinical outcomes.
Data Extraction:
We extracted data and assessed risk of bias in duplicate. We used Grading of Recommendations, Assessment, Development, and Evaluation to assess certainty of evidence.
Limitations:
Trials were heterogeneous, which precluded data pooling.
Results:
Of 2601 publications screened, 10 randomized controlled trials were included. Seven trials were hospital-based (n = 869) and 3 were nonhospital-based (n = 4329). No hospital-based trials evaluated WHO-recommended first-choice regimens. One trial found the WHO-recommended second-choice antibiotic, cefotaxime, to have similar rates of treatment success as non-WHO-recommended regimens of either amoxicillin-clavulanate (RR 0.99, 95% confidence interval 0.82-1.10) or amoxicillin-clavulanate/cefotaxime (RR 1.02, 95% confidence interval 0.86-1.12). Among 3 nonhospital-based trials comparing oral amoxicillin to alternate regimens to treat isolated tachypnea among infants aged 7-59 days, there were no differences in treatment failure between amoxicillin and alternate regimens. Certainty of evidence was low or very low for all primary outcomes.
Conclusions:
We found limited evidence to support the superiority of any single antibiotic regimen over alternate regimens to treat young infant pneumonia.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:21Factors Affecting Drug Response: Overview
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...